Broadfin Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-410,532
| Closed | -$8.04M | – | 55 |
|
|
2018
Q3 | $8.04M | Sell |
410,532
-929,043
| -69% | -$18.2M | 1.18% | 23 |
|
|
2018
Q2 | $22.2M | Sell |
1,339,575
-1,224,600
| -48% | -$20.3M | 3.49% | 9 |
|
|
2018
Q1 | $36.4M | Sell |
2,564,175
-453,846
| -15% | -$6.44M | 5.67% | 4 |
|
|
2017
Q4 | $44.1M | Sell |
3,018,021
-79,943
| -3% | -$1.17M | 7.2% | 2 |
|
|
2017
Q3 | $39.3M | Sell |
3,097,964
-962,883
| -24% | -$12.2M | 5.81% | 4 |
|
|
2017
Q2 | $48.2M | Sell |
4,060,847
-1,603,372
| -28% | -$19M | 5.86% | 3 |
|
|
2017
Q1 | $83.7M | Sell |
5,664,219
-295,600
| -5% | -$4.37M | 10.14% | 1 |
|
|
2016
Q4 | $96.4M | Buy |
5,959,819
+456,637
| +8% | +$7.39M | 10.71% | 1 |
|
|
2016
Q3 | $99.8M | Sell |
5,503,182
-1,360,666
| -20% | -$24.7M | 8.94% | 1 |
|
|
2016
Q2 | $113M | Buy |
6,863,848
+40,471
| +0.6% | +$667K | 10.99% | 1 |
|
|
2016
Q1 | $113M | Sell |
6,823,377
-1,307,933
| -16% | -$21.7M | 10.92% | 1 |
|
|
2015
Q4 | $176M | Buy |
8,131,310
+1,465,919
| +22% | +$31.8M | 10.84% | 1 |
|
|
2015
Q3 | $132M | Buy |
6,665,391
+1,849,584
| +38% | +$36.7M | 7.35% | 1 |
|
|
2015
Q2 | $167M | Sell |
4,815,807
-2,237,697
| -32% | -$77.7M | 8.99% | 1 |
|
|
2015
Q1 | $183M | Sell |
7,053,504
-1,864,471
| -21% | -$48.4M | 14.27% | 1 |
|
|
2014
Q4 | $115M | Buy |
8,917,975
+3,829,092
| +75% | +$49.4M | 10% | 1 |
|
|
2014
Q3 | $62.5M | Buy |
5,088,883
+735,669
| +17% | +$9.03M | 6.55% | 2 |
|
|
2014
Q2 | $68.9M | Buy |
4,353,214
+47,745
| +1% | +$755K | 6.72% | 2 |
|
|
2014
Q1 | $65.1M | Buy |
4,305,469
+48,000
| +1% | +$726K | 6.31% | 2 |
|
|
2013
Q4 | $32.4M | Buy |
4,257,469
+2,377,469
| +126% | +$18.1M | 4.28% | 6 |
|
|
2013
Q3 | $6.3M | Buy |
+1,880,000
| New | +$6.3M | 1.12% | 27 |
|